The Committee of Directors of Natco Pharma Limited has approved a move to raise about Rs 915 crore through qualified institutional placement.
The committee, which met on Friday, approved the issue of one crore equity shares of face value of Rs 2 each to eligible qualified institutional buyers at the issue price of Rs 915 per equity share, including a premium of Rs 913, aggregating to Rs 915 crore, the pharma company informed BSE.